Filgotinib |
非戈替尼 |
1206161-97-8 |
AZD6738 |
AZD6738 |
1352226-88-0 |
PF-05212384 |
N-[4-[[4-(二甲基氨基)-1-哌啶基]羰基]苯基]-N'-[4-[4,6-二(4-吗啉基)-1,3,5-三嗪-2-基]苯基]脲 |
1197160-78-3 |
GS9620 |
GS9620 |
1228585-88-3 |
BAY 87-2243 |
BAY87-2243 |
1227158-85-1 |
2-(2-Chlorophenyl)-4-(3-(diMethylaMino)phenyl)-5-Methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione |
2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮 |
1218942-37-0 |
GSK-2126458 |
GSK2126458 |
1086062-66-9 |
Momelotinib |
莫洛替尼 |
1056634-68-4 |
BMS-794833 |
BMS-794833 |
1174046-72-0 |
LY-2584702 (tosylate salt) |
LY2584702 TOSYLATE |
1082949-68-5 |
WYE-354 |
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯 |
1062169-56-5 |
LY 294002 HYDROCHLORIDE |
LY294002/PI3K抑制剂 |
154447-36-6 |
AZD8931 |
AZD8931 |
848942-61-0 |
N-[[(1,1-DiMethylethyl)aMino]carbonyl]-3-Methyl-L-valine |
N-叔丁基氨基甲酰基-L-叔亮氨酸 |
101968-85-8 |